http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2063916-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1b796e1738da3b2e9f9001ffb04d85b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0457
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0409
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-04
filingDate 2007-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc45a5404fb6bfa8370524bec085d317
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f29d66c13521f71aed6946232138515
publicationDate 2009-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2063916-A2
titleOfInvention X-ray contrast agent for post-mortem experimental and diagnostic angiography
abstract A contrast agent for angiography is disclosed, in particular, for examining animal or human bodies or components thereof such as members or organs thereof, comprising an essentially oil-based apolar contrast component for X-ray examinations, the contrast component having a contrast component viscosity in the range of 30-100 mPas. The contrast agent is characterised in that the contrast component is present in a mixture with at least one further apolar component, the viscosity of which is less than or at most equal to the contrast component viscosity. Methods for angiography examination are also disclosed, in which such a contrast agent or also a polar contrast agent are used at least periodically and applications of such contrast agents.
priorityDate 2006-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127712958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128975680
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11006
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412809
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128222417
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128751714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414340
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33643
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128679028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12389
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410796
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127708637
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127511468
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8567
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4911

Total number of triples: 35.